A Congressional report alleges that consulting firm McKinsey engaged in a “serious conflict of interest” by working for the U.S. government on issues relating to the opioid epidemic while, at the same time, advising drugmakers, including on projects meant to persuade regulators about the safety of opioid products. The U.S. House Oversight Committee alleged in…
McKinsey Accused of ‘Serious’ Conflict of Interest in Opioid Consulting
April 16, 2022
admin
Business & EconomyCompaniesconflict of interestHealth & SafetyLifestyleMcKinseyopioidPoliticsUSUS News
0 Comment
Florida Reaches $878 Million Opioid Settlements With CVS, Teva, Others
Florida has reached more than $878 million in settlements with CVS Health Corp and three drug companies to resolve claims and avert a trial next month over their roles in fueling an opioid epidemic in the third most populous U.S. state. CVS will pay $484 million, Teva Pharmaceutical Industries Ltd will pay $194.8 million, Abbvie…
Purdue Pharma, US States Agree to New Opioid Settlement
Purdue Pharma reached a nationwide settlement Thursday over its role in the opioid crisis, with the Sackler family members who own the company boosting their cash contribution to as much as $6 billion in a deal intended to staunch a flood of lawsuits facing the maker of OxyContin. The deal follows an earlier settlement that…
Vaccine Maker Johnson & Johnson Settles Huge Lawsuit Over Role in Opioid Crisis
Pharmaceutical giant Johnson & Johnson on Friday agreed to a $26 billion settlement to thousands of claims by local and state governments of the alleged role that it and several others played in the U.S. opioid crisis. Distributors McKesson Corp, AmerisourceBergen Corp, and Cardinal Health Inc. joined in on the settlement, agreeing to pay $21…
Purdue’s Sackler Owners Propose up to $6 Billion Opioid Settlement
The Sackler family owners of Purdue Pharma LP have proposed a new and larger settlement worth up to $6 billion to resolve allegations that the OxyContin maker and its owners contributed to the deadly U.S. opioid epidemic, a mediator’s report showed on Friday. The mediator, U.S. Bankruptcy Judge Shelley Chapman, has been overseeing talks between…
CDC Proposes New Guidelines for Prescribing Opioids, Dropping Specific Dosage Recommendations
The Centers for Disease Control and Prevention (CDC) has proposed new opioid prescribing guidelines that will drop its prior recommendation of specific limits on doses of opioid painkillers when treating chronic pain patients, among other changes. The proposed update seeks to amend the CDC’s current guideline for prescribing opioids, issued in 2016, which had sparked…
Illicit Drugs in BC Cause More Deaths Than All Other Unnatural Deaths Combined: Chief Coroner
Toxic illegal drugs in British Columbia are causing more deaths annually than all other unnatural causes of death combined according to the province’s chief coroner. Speaking at a press conference on Feb. 9, Chief Coroner Lisa Lapointe said at least 2,224 people died from illicit drug overdoses in 2021—a 26 percent rise over the previous…
Purdue Pharma Bankruptcy Mediator Says Sacklers, US States Closer to Deal Over Opioid Claims
A mediator reported on Tuesday that members of the Sackler family that own Purdue Pharma and U.S. states opposed to the OxyContin-maker’s bankruptcy exit plan are “even closer” to a settlement over claims that the company fueled a U.S. opioid epidemic. The mediator asked a bankruptcy judge to extend the deadline for negotiations to Feb….
J&J and Drug Distributors to Pay $589 Million Settlement to Native American Tribes Over Opioid Crisis
Johnson & Johnson (J&J) and three of the nation’s largest drug wholesalers and distributors have agreed to pay $589 million in settlement after hundreds of native tribes accused the companies of fueling the opioid crisis in their communities. The three pharmaceutical distributors—Cardinal Health, AmerisourceBergen Corp., and McKesson Corp.—will pay more than $439 million in settlement…
Sacklers Near Deal to Increase Opioid Settlement in Purdue Bankruptcy
Members of the Sackler family who own Purdue Pharma LP. are nearing an agreement to boost their more than $4 billion offer to resolve sprawling opioid litigation after negotiating with states that had objected to terms of the OxyContin maker’s bankruptcy reorganization, according to a court filing. Sackler family members and states objecting to terms…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta